SERVICES
End-to-End Sourcing Solutions
From single comparator procurement to full-scale clinical supply programs, Solis BioSciences customized solutions tailored to the unique demands of your study.
Comparator Drug Sourcing
Access the branded or generic reference products your clinical trial requires — anywhere in the world.
We source comparator drugs directly from licensed manufacturers, authorized wholesalers, and regulated pharmacy channels. Whether you need a single batch or a multi-site, multi-year supply program, we customize a solution around your protocol.
Reference Listed Drugs (RLD) Sourcing
Secure the FDA- or Health Canada-approved reference product your biosimilar or generic development program demands.
Solis BioSciences provides reliable, timely access to reference listed drugs for ANDA and biosimilar submissions. We understand the unique regulatory and documentation requirements that come with RLD procurement, ensuring your supply is compliant, defensible, and delivered on schedule.
Regulatory & Documentation Support
Navigate the paperwork. We handle it.
Cross-border pharmaceutical procurement involves a complex web of import permits, controlled substance licensing, agency notifications, and country-specific compliance requirements. Our team prepares and manages all documentation to ensure your shipments clear customs and satisfy your regulatory file.
Ancillary & Clinical Supply
Beyond the drug. Everything your trial needs.
We source and coordinate clinical trial ancillaries — diluents, devices, administration supplies, and packaging materials — alongside your investigational or comparator product. A single point of contact for your full supply chain.
WHO WE SERVE
Contract Research Organizations (CROs)
CROs operate under relentless timeline pressure. When a comparator arrives late, off-spec, or underdocumented, your entire trial schedule absorbs the cost. Solis BioSciences exists to remove that risk. We function as a dedicated sourcing arm, handling procurement, import logistics, and regulatory documentation so your team can stay focused on study execution. One supplier. One point of contact. No surprises.
CDMOs & Biosimilar Developers
Biosimilar and generic development lives or dies on the quality of its reference product supply. Health Canada, the FDA, and the EMA each have specific expectations for how reference listed drugs are procured, documented, and traced — and your dossier will reflect every gap. Solis BioSciences sources RLDs and innovator comparators with the chain-of-custody documentation, certificates of authenticity, and regulatory traceability your submission requires. We source to your specification, not ours.